WST
West Pharmaceutical Services, Inc.
Healthcare
$316.13
as of May 21, 2026
Sign in to add WST to your portfolio.
Sign inMarket cap
$21.58B
P/E (TTM)
40.5x
EPS (TTM)
$7.54
Dividend yield
0.28%
Annual financials
| FY | Revenue | Net income | FCF | Gross margin | Op. margin | EPS (diluted) |
|---|---|---|---|---|---|---|
| 2021 | $2.83B | $661.80M | $330.60M | 41.5% | 26.8% | $8.90 |
| 2022 | $2.89B | $585.90M | $439.40M | 39.5% | 26.5% | $7.88 |
| 2023 | $2.95B | $593.40M | $414.50M | 38.4% | 24.1% | $7.99 |
| 2024 | $2.89B | $492.70M | $276.40M | 34.6% | 20.6% | $6.75 |
| 2025 | $3.07B | $493.70M | $468.90M | 35.9% | 20.1% | $6.83 |
Recent prices
| Date | Open | Close | Volume |
|---|---|---|---|
| May 21, 2026 | $308.17 | $316.13 | 743.51K |
| May 20, 2026 | $303.99 | $305.50 | 634.89K |
| May 19, 2026 | $304.38 | $303.93 | 565.54K |
| May 18, 2026 | $304.35 | $304.41 | 498.39K |
| May 15, 2026 | $296.76 | $302.89 | 686.42K |
| May 14, 2026 | $301.70 | $300.19 | 700.51K |
| May 13, 2026 | $310.44 | $302.40 | 718.40K |
| May 12, 2026 | $312.33 | $312.07 | 1.12M |
| May 11, 2026 | $327.46 | $322.30 | 879.40K |
| May 08, 2026 | $323.50 | $325.92 | 1.03M |
| May 07, 2026 | $315.28 | $322.01 | 1.61M |
| May 06, 2026 | $311.31 | $312.55 | 789.20K |
| May 05, 2026 | $302.52 | $309.97 | 896.96K |
| May 04, 2026 | $299.35 | $300.18 | 472.23K |
| May 01, 2026 | $294.27 | $300.68 | 651.74K |
| Apr 30, 2026 | $295.58 | $297.59 | 1.11M |
| Apr 29, 2026 | $296.25 | $295.36 | 796.40K |
| Apr 28, 2026 | $301.91 | $292.13 | 1.19M |
| Apr 27, 2026 | $304.40 | $302.20 | 1.14M |
| Apr 24, 2026 | $316.00 | $306.16 | 1.29M |
| Apr 23, 2026 | $308.01 | $309.70 | 2.73M |
| Apr 22, 2026 | $275.83 | $274.41 | 1.01M |
| Apr 21, 2026 | $278.00 | $274.72 | 947.80K |
| Apr 20, 2026 | $271.90 | $278.00 | 1.01M |
Profitability & balance
- ROE (TTM)
- 17.9%
- Gross margin
- 36.2%
- Operating margin
- 20.7%
- Net margin
- 16.9%
- Debt / equity
- 0.11